AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Lexeo Therapeutics, Inc. Common Stock

$3.14 -$6.47 (-67.33%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$3.06
Day Range
$2.90$3.29
Year Range
$2.55$10.99
Market Cap
257.76M
AVG Volume
1.21M
Trailing/Forward PE
-2.73/-
PEG ratio
0.07
Dividend Yield
-
Next Earnings Date
2026-12-14
Primary Exchange
NASDAQUS
Revenue (USD) · A
0200K400K600K800K2022202320242025
LXEO Revenue (USD) by year
PeriodRevenue (USD)
20250
20240
20230
2022653.55K
Net Income (USD) · A
-100M-75M-50M-25M02022202320242025
LXEO Net Income (USD) by year
PeriodNet Income (USD)
2025-99.96M
2024-98.33M
2023-66.39M
2022-59.28M
Operating Income (USD) · A
-150M-100M-50M02022202320242025
LXEO Operating Income (USD) by year
PeriodOperating Income (USD)
2025-109.26M
2024-105.77M
2023-68.51M
2022-60.51M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: LXEO

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 14 Dec 2026.

Lexeo Therapeutics, Inc. Common Stock
LXEO
Stockpicker

Video analysis: LXEO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: LXEO

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.